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General Methods.
All reactions were run under an atmosphere of dry argon using oven-dried 
glassware and freshly distilled and dried solvents. THF and diethyl ether were distilled 
from sodium benzophenone ketyl. Dichloromethane was distilled from calcium hydride. 
TLC was performed on Silica Gel GF254 (Merck) with detection by charring with 
phosphomolybdic acid/EtOH and sulphuric acid/EtOH. Reagents were obtained from 
commercial suppliers and used without further purification. For flash chromatography, 
silica Gel (Merck 230-400 mesh) was used. Columns were eluted with positive air 
pressure. Chromatographic eluents are given as volume to volume ratios (v/v). NMR 
spectra were recorded with a Bruker AMX500 (1H, 500 MHz) and Bruker Avance 
DRX500 (1H, 500 MHz) spectrometers. Chemical shifts are reported in ppm, and 
coupling constants are reported in Hz. Routine spectra were referenced to the residual 
proton or carbon signals of the solvent. High-resolution mass spectra were recorded on 
a Kratos MS-80RFA 241-MC apparatus. Optical rotations were determined with a 
Perkin-Elmer 341 polarimeter. Elemental analyses were recorded on a leco CHNS-932 
apparatus. The organic extracts were dried over anhydrous sodium sulfate and 
concentrated under vacuum.
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The synthesis of (2’ ethylamino) per-O-acetylated-1-thio-glycosides 1 and 2 was 
done in a one step manner from the corresponding peracetylated sugars and will be 
reported in due course. The hydrophilic spacer 3 was obtained from tetraethylene glycol 
in three steps using the following Scheme 1. 
Scheme 1: Synthesis of the hydrophilic spacer 3.
The synthesis of neoglycoconjugates Py-PEG-Lac-5, and Py-PEG-Man-6 has been done 
following Scheme 2.
Scheme 2: General synthetic method followed for the synthesis of 
neoglycoconjugates Py-PEG-Lac-5, and Py-PEG-Man-6
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Synthesis of alkyne 4 
1-Pyreneacetic acid (200 mg, 0.77 mmol) was dissolved in DMF (3.8 mL). O-
Benzotriazol-1-yl-N,N,N´,N´-tetramethyluronium tetrafluoroborate (271 mg, 0.85 
mmol) and N,N-diisopropylethylamine  (DIPEA) (134 µL, 0.77 mmol) were added 
sequentially at room temperature. The solution was stirred for 5 min before a solution of 
propargylamine (53 µL, 0.77 mmol) and DIPEA (267 µL, 1.54 mmol) in DMF (7.7 mL) 
were added slowly. The solution was stirred overnight before the solvent was removed 
under vacuum. The residue was dissolved in CH2Cl2 (100 mL) and washed with 1M 
HCl (20 mL), saturated aqueous NaHCO3 (40 mL) and brine (20 mL). After drying over 
Na2SO4 and removal of solvent, the crude product was purified by silica gel 
chromatography eluting with hexane/ethylacetate (3:1) to give 210 mg of an amorphous 
yellow solid 4 (99% yield): Rf = 0.43 (Hex/EtOAc 1:1). 1H NMR (400 MHz, CDCl3)  : 
8.35-7.90 (m, 9H), 5.48 (s, 1H), 4.36 (s, 2H), 3.95 (s, 2H), 2.07 (s, 1H). 13C NMR 
(125.7 MHz, CDCl3)  : 170.5, 131.1, 130.7, 129.5, 127.2, 126.2, 125.5, 125.4, 125.0, 
122.7, 79.0, 71.3, 41.7, 29.2. HRMS Calcd. for C21H15NONa [M+Na]+: m/z 297.1154. 
Found: 297.1148
Synthesis of spacer 3 (See scheme A),
A solution of tetraethylene glycol 3a (22.7 mL, 140 mmol), Et3N (15 mL) and 
THF (100 mL) was cooled to 0ºC. To this was added dropwise methanesulfonyl 
chloride solution (10.8 mL, 140 mmol). The reaction mixture was then allowed to warm 
to room temperature and stirred vigorously overnight. The solution was diluted with 
CH2Cl2 (250 mL) and washed with saturated NH4Cl (50 mL) and brine (20 mL). The 
organic solution was dried over Na2SO4 and concentrated in vacuum to give the crude 
product. The oily residue was purified by flash column chromatography, eluting with 
dichlorometane/methanol (20:1) to give 12.9 g of the mesylated compound 3b as an oil 
(37% yield): Rf = 0.5 in dichlorometane/methanol (9:1). 1H NMR (500 MHz, CDCl3) 
4.41- 4.35 (m, 2H), 3.81-3.60 (m, 14H),  3.09 (s, 3H), 2.97 (s, 1H). 13C NMR (125.6 
MHz, CDCl3) 72.5, 70.4, 70.3, 70.1, 69.4, 68.9, 61.4, 37.4. HRMS Calcd. for 
C9H20O7SNa [M+Na]+: m/z 273.1008. Found: 273.0997.
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A mixture of mesylated compound 3b (9.1 g, 33.4 mmol) and sodium azide (2.4 
g., 36.8 mmol) in ethanol (50 mL) was heated at reflux overnight, cooled to room 
temperature and concentrated in vacuo. The residue was diluted with ether (250 mL), 
washed with brine (50 mL), and dried over Na2SO4. Solvent was removed under 
vacuum to yield the crude product, which was purified by flash column 
chromatography, eluting with a gradient of hexane/ethyl acetate (1:1) to give 6.4 g of 
the azide 5c as an oil (97% yield): Rf = 0.18 in hexane/ethyl acetate (1:1). 1H NMR (500 
MHz, CDCl3)  3.58 (t, 2H, J = 4.8 Hz), 3.57-3.51 (m, 10H), 3.46 (t, 2H, J = 4.8 Hz), 
3.26 (t, 2H, J = 4.8 Hz), 3.10 (brs, 1H). 13C NMR (125.7 MHz, CDCl3)  72.5, 70.6, 
70.5, 70.4, 70.2, 69.9, 61.5, 50.5. HRMS calcd for C8H17N3O4Na [M+Na]+: m/z 
220.1297. Found: 220.1288.
A solution of azido alcohol 3c (2.4 g, 10 mmol) in acetone (100 mL) was cooled 
to 0ºC. To this was added freshly prepared Jones reagent (44 mL). The reaction mixture 
was then allowed to warm to room temperature and stirred vigorously overnight. To the 
orange suspension was added dropwise propan-2-ol until the green colour was 
observed, then the reaction mixture was filtered over Celite® to remove chromium (IV) 
oxide and concentrated in vacuum to give the crude product. The oil residue was 
purified by flash column chromatography, eluting with dichloromethane/methanol (9:1) 
to give 1.8 g of 3 as an oil (75% yield): Rf = 0.4 in dichloromethane/methanol (9:1). 1H 
NMR (500 MHz, CDCl3)  9.30 (brs, 1H), 4.20-4.10 (m, 2H), 3.80-3.60 (m, 10H), 
3.40-3.20 (m, 2H). 13C NMR (125.7 MHz, CDCl3)  173.5, 70.9, 70.4, 70.3, 70.2, 69.9, 
68.3, 50.5. HRMS calcd for C8H15N3O5Na [M+Na]+: m/z 234.1089. Found: 234.1085.
Synthesis of Compound PEG-Lac-7
The azido acid 3  (68 mg, 0.29 mmol) was dissolved in DMF (0.5 mL). O-Benzotriazol-
1-yl-N,N,N´,N´-tetramethyluronium tetrafluoroborate (93 mg., 0.29 mmol) and DIPEA 
(70 µL, 0.43 mmol) were added sequentially at room temperature. The solution was 
stirred for 5 min before a solution of lactose derived amine 1 (223 mg., 0.29 mmol) and 
DIPEA (70 µL, 0.43 mmol) in DMF (1 mL) was added slowly. The solution was stirred 
O
OAc
S
N
H
O
AcO
AcO
OAc
AcOO
OAc AcO
O
O
O
N3
O
PRIVILEGED DOCUMENT FOR REVIEW PURPOSES ONLY
SI-7
for 2 h before the solvent was removed under vacuum. The residue was dissolved in 
CH2Cl2 (100 mL) and washed with 1M HCl (20 mL), saturated aqueous NaHCO3 (40 
mL) and brine (20 mL). After drying over Na2SO4 and removal of solvent, the crude 
product was purified by silica gel chromatography eluting with 
dichloromethane/methanol 20:1 to give 225 mg of a yellow oil PEG-Lac-7 (85% yield): 
Rf = 0.21 (CH2Cl2/MeOH 20:1); []D = -7.66 (c 0.85, CHCl3). 1H NMR (500 MHz, 
CDCl3)  7.20 (t, 1H, J = 1.1 Hz), 5.33 (d, 1H, J = 2.4 Hz), 5.18 (t, 1H, J = 9.2 Hz), 
5.08 (t, 1H, J = 10.0 Hz), 4.97-4.89 (m, 2H), 4.55-4.45 (m, 3H), 4.15-4.05 (m, 3H), 3.98 
(s, 2H), 3.85 (t, 1H, J = 6.8 Hz), 3.77 (t, 1H, J = 9.5 Hz), 3.70-3.60 (s, 11H), 3.60-3.40
(m, 2H), 3.38 (t, 2H, J = 4.9 Hz), 2.80-2.83 (m, 1H), 2.80 (s, 1H), 2.78-2.70 (m, 1H), 
2.13 (m, 3H), 2.09 (s, 3H), 2.04 (s, 3H), 2.03 (s, 3H), 2.02 (s, 6H), 1.94 (s, 3H). 13C 
NMR (125.7 MHz, CDCl3) 170.3, 170.1, 170.0, 169.9, 169.6 (2C), 169.0, 101.1, 
83.7, 76.1, 73.7, 71.0, 70.8, 70.7, 70.6, 70.5, 70.4, 70.3, 70.2, 70.0, 69.1, 66.6, 62.1, 
60.8, 50.6, 38.9, 30.4, 20.8, 20.7, 20.6. HRMS calcd for C36H54N4O21SNa [M+Na]+: 
m/z 933.2899. Found: 933.2854.
Synthesis of Compound PEG-Man-8
The azido acid 3 (190.5 mg, 0.82 mmol) was dissolved in DMF (2 mL). O-
Benzotriazol-1-yl-N,N,N´,N´-tetramethyluronium tetrafluoroborate (262 mg, 0.82 
mmol) and DIPEA (194 µL, 1.1 mmol) were added sequentially at room temperature. 
The solution was stirred for 5 min before a solution of 2’ ethyl amino-(2,3,4-tetra-O-
acetyl-1-thio)--manopyranoside 2 (300 mg, 0.74 mmol) and DIPEA (194 µL, 1.1 
mmol) in DMF (2 mL) was added slowly. The solution was stirred for 2 h before the 
solvent was removed under vacuum. The residue was dissolved in CH2Cl2 (100 mL) and 
washed with 1M HCl (20 mL), saturated NaHCO3 aqueous solution (40 mL) and brine 
(20 mL). After drying over Na2SO4 and removal of solvent, the crude product was 
purified by silica gel chromatography eluting with ethyl acetate to give 414 mg of a 
yellow oil Py-PEG-Man-8 (90% yield): Rf = 0.25 in ethyl acetate. []D = + 43.6 (c 1.1, 
CHCl3). 1H NMR (500 MHz, CDCl3) : 7.27 (brs, 1H), 5.35-5.20 (m, 4H), 4.40-4.30
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(m, 1H), 4.28 (dd, 1H, J = 12.2 Hz, J =5.5 Hz), 4.09 (dd, 1H, J = 12.2 Hz, J = 1.7 Hz), 
3.99 (s, 2H), 3.70-3.60 (m, 10H), 3.54-3.51 (m, 2H), 3.38 (t, 2H, J = 4.9 Hz), 2.85-2.60
(m, 2H), 2.15 (s, 3H), 2.07 (s, 3H), 2.04 (s, 3H), 1.97 (s, 3H). 13C NMR (125.7 MHz, 
CDCl3) : 170.6, 170.1, 169.9, 169.8, 82.5, 71.0, 70.9, 70.7, 70.6, 70.5, 70.4, 70.3, 70.0,
69.4, 69.1, 66.3, 62.4, 50.7, 38.1, 31.1, 31.0, 20.8, 20.7, 20.6. HRMS calcd for 
C24H38N4O13SNa [M+Na]+: m/z 645.2054. Found: 645.2046.
Synthesis of compound Py-PEG-Lac-9
To a solution of the azide PEG-Lac-7 (81.5 mg., 0.09 mmol) and the alkyne  4 (29 mg, 
0.10 mmol) in anhydrous CH2Cl2 (2 mL), were added DIPEA (47 µL, 0.27 mmol) and 
Bromotris(triphenylphosphine)copper(I) (8.3 mg., 0.01 mmol). The resulting solution 
was stirred under argon overnight at room temperature. After dilution with 
dichloromethane (100 mL), washing with 1M HCl (20 mL), saturated aqueous NaHCO3
(40 mL) and brine (20 mL), the organic phase was dried over Na2SO4 and evaporated 
under reduced pressure. The crude product was purified by silica gel chromatography 
eluting with ethylacetate/methanol (9:1) to give 46 mg of a yellow oil Py-PEG-Lac-9
(56% yield): Rf  = 0.6 (EtOAc/MeOH 9:1). []D = -5.35 (c 0.6, MeOH). 1H NMR (500 
MHz, CDCl3)  : 8.25-7.95 (m, 9H), 7.55 (s, 1H), 7.21 (t, 1H, J= 5.7 Hz), 6.35 (t, 1H, J
= 5.7 Hz), 5.40-5.20 (m, 5H), 4.50-4.30 (m, 9H), 4.15-4.05 (m, 4H), 3.80-3.70 (m, 2H), 
3.59-3.54 (m, 2H), 3.50-3.45(m, 9H), 2.85-2.65 (m, 2H), 2.13, 2.09, 2.04, 2.02 (4s, 
21H). 13C NMR (100.6 MHz, CDCl3) 170.9, 170.2, 170.0, 169.8, 169.5, 169.0, 
131.2, 130.9, 130.6, 129.4, 128.4, 128.2, 127.4, 127.2, 126.1, 125.4, 125.2, 125.0, 
124.5, 123.0, 101.0, 83.5, 76.0, 73.5, 70.9, 70.6, 70.5, 70.4, 70.1, 69.1, 69.0, 66.5, 62.0, 
60.6, 50.0, 41.7, 38.7, 35.0, 30.3, 20.6, 20.5, 20.4, 20.3. HRMS calcd for 
C57H69N5O22SNa [M+Na]+: m/z 1230.4053. Found: 1230.4053.
Synthesis of compound Py-PEG-Man-10
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To a solution of the azide PEG-Man-8 (111 mg, 0.18 mmol) and the alkyne 4 (55 mg, 
0.20 mmol) in anhydrous CH2Cl2 (2 mL), were added DIPEA (93µL, 0.54mmol) and 
Bromotris(triphenylphosphine)-cooper(I) (17 mg, 0.02 mmol). The resulting solution 
was stirred under argon overnight at room temperature. After dilution with 
dichloromethane (100 mL), washing with 1M HCl (20 mL), saturated aqueous NaHCO3
(40 mL) and brine (20 mL), the organic phase was dried over Na2SO4 and evaporated 
under reduced pressure. The crude product was purified by silica gel chromatography 
eluting with ethylacetate/methanol (9:1) to give 90 mg of the triazol Py-PEG-Man-10 as 
a yellow oil  (53% yield): Rf  = 0.29 (EtOAc/MeOH 9:1). []D = 28.4 (c 0.5, MeOH). 1H 
NMR (500 MHz, CDCl3)  : 8.30-7.90 (m, 9H), 7.55 (s, 1H), 7.20 (t, 1H, J = 6.3 Hz), 
6.30 (t, 1H, J = 5.9 Hz), 5.40-5.20 (m, 4H), 4.50-4.25 (m, 7H), 4.10 (d, 1H, J = 11.8 
Hz), 3.94 (s, 2H), 3.76 (t, 2H, J = 5.0 Hz), 3.6 (s, 2H), 3.60-3.40 (m, 9H), 2.85-2.65 (m, 
2H), 2.15 (s, 3H), 2.07 (s, 3H), 2.04 (s, 3H), 1.97 (s, 3H). 13C NMR (125.7 MHz, 
CDCl3)  : 171.1, 170.6, 170.0, 169.9, 169.8, 169.6, 144.5, 131.3, 131.0, 130.8, 129.5, 
129.0, 128.5, 128.4, 128.3, 128.2, 127.5, 127.4, 126.2, 125.5, 125.3, 125.1, 124.6, 
123.1, 123.0, 82.4, 70.9, 70.8, 70.5, 70.4, 70.3, 70.1, 69.4, 69.2, 69.1, 66.2, 62.4, 50.1, 
41.8, 38.0, 35.1, 31.1, 20.9, 20.7, 20.6, 20.4. HRMS calcd for C45H53N5O14SNa 
[M+Na]+: m/z 942.3207. Found: 942.3220.
Synthesis of Compound Py-PEG-Lac-5
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To a solution of Py-PEG-Lac-9 (50 mg, 0.04 mmol) in dry methanol (1 mL) was added 
NaOMe (1.7 mg, 0.03 mmol). The reaction was allowed to proceed at rt for 1 h at which 
time the reaction was judged complete by TLC analysis. A sufficient quantity of 
Amberlyst Ir-120 (plus) (H+. form) resin was added to the mixture to render the pH of 
the solution neutral. The resin was removed by filtration and the solvent removed under 
vacuum. The crude product was purified by size-exclusion chromatography (sephadex® 
20) eluting with methanol. Lyophylization of the solvent gave 40 mg of a white solid 
Py-PEG-Lac-5 (80% yield): Rf = 0.62 (MeCN/H2O/NH4OH 6:1:1); []D = -4.87 (c 0.9, 
MeOH). 1H NMR (500 MHz, MeOD)  : 8.53 (brs, 1H), 8.29-7.95 (m, 9H), 7.72 (s, 1 
H), 4.50-4.30 (m, 9H), 3.90-3.20 (m, 26 H), 2.90-2.60 (m, 2 H). 13C NMR (125.7 MHz, 
MeOD):173.9, 172.8, 132.7, 132.1, 132.0, 130.7, 129.7, 128.8, 128.5, 128.2, 127.2, 
126.3, 126.2, 1126.1, 126.0, 125.8, 124.6, 105.1, 86.9, 80.5, 80.5, 77.8, 77.1, 74.8, 74.1, 
72.5, 71.8, 71.5, 71.3, 71.2, 70.3, 70.2, 62.5, 62.1, 51.4, 50.0, 41.6, 40.4, 35.9, 30.5. 
HRMS calcd for C43H55N5O15SNa [M+Na]+: m/z 936.3313. Found: 936.3313.
Synthesis of Compound Py-PEG-Man-6
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To a solution of Py-PEG-Man-10 (90 mg, 0.10 mmol) in dry methanol (1 mL) was 
added NaOMe (2.1 mg, 0.04 mmol). The reaction was allowed to proceed at RT for 1 h 
at which time the reaction was judged complete by TLC analysis. A sufficient quantity 
of Amberlyst Ir-120 (plus) (H+. form) resin was added to the mixture to render the pH 
of the solution neutral. The resin was removed by filtration and the solvent removed 
under vacuum. The crude product was purified by size-exclusion chromatography 
(sephadex® G20) eluting with methanol. Lyophylization of the solvent gave 50 mg of a 
yellow solid Py-PEG-Man-6 (56% yield) Rf = 0.33 (CH2Cl2/MeOH 9:1); []D = + 43.8 
(c 0.6, MeOH). 1H NMR (500 MHz, MeOD)  : 8.23-7.92 (m, 9H), 7.69 (s, 1H), 5.27 
(s, 1H), 4.45 (s, 2H) ,4.41 (t, 2H, J = 5.2 Hz), 4.26 (s, 2H), 3.94-3.80 (m, 6H), 3.75-3.60
(m, 6H), 3.45-3.25 (m, 14H), 2.80-2.60 (m, 2H). 13C NMR (125.7 MHz, MeOD)  : 
173.9, 172.8, 146.2, 132.7, 132.1, 131.9, 130.6, 129.4, 128.4, 128.2, 127.4, 127.2, 
126.1, 125.4, 125.2, 125.0, 124.5, 86.5, 75.2, 73.6, 73.1, 71.7, 71.1, 71.0, 70.1, 68.9, 
62.8, 51.3, 41.5, 39.6, 35.9, 31.4. HRMS calcd for C37H45N5O10SNa [M+Na]+: m/z 
774.2785. Found: 774.2774.
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Functionalization of MWNTs and SWNTs with the neoglycolipids Py-PEG-Lac-5 
and Py-PEG-Man-6. 
In a typical preparation experiment, 0.5 mg of CNTs (Nanoledge, and mer) was 
suspended in 1 ml of aqueous glycolipid solution. The mixture was sonicated using a 
water-bath sonicator for 1 h, then was incubated all the night, after that the mixture was 
sonicated another 30 mins. The insoluble material was removed by centrifugation.
TEM characterization of the aggregates. 
TEM images of glycolipid-coated CNTs were obtained on a Philips CM-200 
operating at electron energy of 200 keV and magnification of 10-300 thousand times. 
Samples were prepared by depositing 15 μl of the suspension onto grids, allowing the 
grids to absorb for 2 mins. 
a. b.
Figure S1: a. TEM image MWCNTs-Py-PEG-Man-6, b. TEM image SWCNTs-Py-
PEG-Man-6. 
SEM Characterization. 
SEM images of glycolipid-coated CNTs were obtained on a JEOL JSM-5400
magnification of 15 thousand times. Samples were prepared by depositing 15 μl of the 
suspension onto grids, allowing the grids to absorb for 2 mins. 
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a.              b.
Figure S2: a. SEM image of MWCNTs-Py-PEG-Lac-5, b. SEM image of MWCNTs-
Py-PEG-Man-6
Lectin binding assay.
A 1 mL solution of PNA-FITC (100 μg/mL) in buffer (0.10 M Tris, and 0.15 M 
NaCl, pH 8.0) was added to the suspensions of glycolipid-coated nanotubes in H2O (1 
mL). An additional 0.5 mL buffer was added and the reactions were incubated all the 
night at rt in the dark. Lactose inhibition of PNA binding to glycolipid-CNTs was tested 
by pre-incubating 1 mL of PNA-FITC solution in buffer (100 μg/mL) with 0.5 ml of 
lactose in buffer (500 mg/mL) for 1h at rt in the dark. This pre-incubated solution was 
added to the suspension of glycolipid-CNTs in H2O (1 mL), and the resulting solution 
was incubated all the night at rt in the dark, as described above. After incubation, the 
solutions were centrifuged three times for removing the unreacted lectins. The 
centrifuged solutions were analyzed at 510-550 nm using a fluorescence microplate 
reader (excitation wavelength 492 nm). 
